发明名称 |
PYRIMIDONE COMPOUNDS |
摘要 |
A pyrimidone derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof: wherein X represents hydrogen atom and Y represents hydroxyl group, or X represents fluorine atom and Y represents hydrogen atom; R1 represents a C1-6 alkyl group; R2 represents a morpholin-4-yl group which may be substituted, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease). |
申请公布号 |
US2012220591(A1) |
申请公布日期 |
2012.08.30 |
申请号 |
US201013389504 |
申请日期 |
2010.08.11 |
申请人 |
SAKAI DAIKI;NAKAYAMA KAZUKI;WATANABE KAZUTOSHI;SANOFI;MITSUBISHI TANABE PHARMA CORPORATION |
发明人 |
SAKAI DAIKI;NAKAYAMA KAZUKI;WATANABE KAZUTOSHI |
分类号 |
A61K31/5377;A61P3/04;A61P3/10;A61P9/10;A61P25/00;A61P25/02;A61P25/16;A61P25/18;A61P25/28;A61P27/02;A61P27/06;A61P33/06;A61P35/00;A61P35/02;C07D413/14 |
主分类号 |
A61K31/5377 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|